title: Bacteriophages carrying Shiga toxin genes: genomic variations, detection and potential treatment of pathogenic bacteria.
abstract: Although most Escherichia coli strains occur in the mammalian intestine as commensals, some of them, including enterohemorrhagic E. coli (EHEC), are capable of causing disease in humans. The most notorious virulence factors of EHEC are Shiga toxins, encoded by genes located on genomes of lambdoid prophages. Production and release of these toxins is strongly stimulated after the induction of these prophages. Many antibiotics used to treat bacterial infections stimulate induction of Shiga toxin-converting prophages, enhancing severity of the disease symptoms. Hence, treatment with antibiotics is not recommended if infection with EHEC is confirmed or even suspected. In this light, rapid detection of EHEC is crucial, and understanding the mechanisms of prophage induction and phage development in the human intestine is important to facilitate development of procedures preventing or alleviating Shiga toxin-caused diseases.
authors.affiliation: Department of Molecular Biology, University of Gdansk, Kladki, Poland.
authors.forename: Joanna M
authors.initials: JM
authors.lastname: Loś
authors.forename: Marcin
authors.initials: M
authors.lastname: Loś
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Węgrzyn
mesh_terms: D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use; D003090:Coliphages / Q000187:drug effects / Q000235:genetics*; D054324:Enterohemorrhagic Escherichia coli / Q000821:virology*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000382:microbiology; D005814:Genes, Viral; D006801:Humans; D039002:Prophages / Q000187:drug effects / Q000235:genetics; D022621:Shiga Toxin / Q000096:biosynthesis / Q000235:genetics*; D014775:Virus Activation / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents; D022621:Shiga Toxin